Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Chris Lange | Mar 25, 2019 at 9:05 AM EDT

Picking Up the Pieces: How Biogen Is Dealing With Discontinued Alzheimer’s Trial

Biogen shares made a slight gain early on Monday after the firm made an SEC filing indicating that it will…

Jon C. Ogg | Mar 22, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Best Buy, Biogen, Booking, China Mobile, Chipotle, CNOOC, Kinder Morgan, Lumentum, MongoDB, Nike and More

The top analyst upgrades, downgrades and initiations seen on Friday included Best Buy, Biogen, China Mobile, Chipotle Mexican Grill, CNOOC,…

Jon C. Ogg | Mar 21, 2019 at 4:24 PM EDT

Is Neurotrope the Default Alzheimer’s Winner After Biogen’s Implosion?

Neurotrope Inc. (NASDAQ: NTRP) may be a winner by default in the battle against Alzheimer’s disease after shares of Biogen…

Chris Lange | Mar 21, 2019 at 4:08 PM EDT

Thursday’s Biggest Winners and Losers in the S&P 500

Thursday was a very positive day for the broad U.S. markets. The S&P 500 and DJIA pushed higher in the…

Chris Lange | Mar 21, 2019 at 9:55 AM EDT

Why This Alzheimer’s Study Is Crushing Biogen Shares

Biogen shares were crushed in Thursday’s session after the firm announced that it would be discontinuing its late-stage trial for…

Chris Lange | Mar 12, 2019 at 9:05 AM EDT

Major Biotechs See a Rising Tide in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 4, 2019 at 8:30 AM EST

Are Nightstar Shareholders Getting Enough in the Buyout?

Nightstar Therapeutics shares exploded early on Monday after it was announced that the firm would be acquired by Biogen. The…

Chris Lange | Feb 28, 2019 at 8:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data…

Jon C. Ogg | Feb 22, 2019 at 8:52 AM EST

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck,…

Trey Thoelcke | Feb 22, 2019 at 8:00 AM EST

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a…

Jon C. Ogg | Feb 21, 2019 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Agilent, American Water, Apple, Biogen, Garmin, GoDaddy, Tilray, UBS, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Agilent Technologies, American Water Works, Apple, Biogen, Garmin, GoDaddy,…

Jon C. Ogg | Feb 13, 2019 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Activision, Biogen, Deere, DocuSign, Ford, Freeport-McMoRan, GM, Lattice Semi, Qualys, Shopify, Under Armour and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Activision Blizzard, Biogen, Deere, DocuSign, Ford, Freeport-McMoRan, General Motors,…

Chris Lange | Feb 12, 2019 at 9:55 AM EST

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data…

Jon C. Ogg | Jan 29, 2019 at 3:01 PM EST

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower…

Chris Lange | Jan 28, 2019 at 8:30 AM EST

Short Sellers Back Off Major Biotechs

The January 15 short interest data have been compared with the previous report, and short interest in most of the…

1 … 9 10 11 12 13 … 41

Biogen : BIIB

All Biogen Articles

Picking Up the Pieces: How Biogen Is Dealing With Discontinued Alzheimer’s Trial

Top Analyst Upgrades and Downgrades: Best Buy, Biogen, Booking, China Mobile, Chipotle, CNOOC, Kinder Morgan, Lumentum, MongoDB, Nike and More

Is Neurotrope the Default Alzheimer’s Winner After Biogen’s Implosion?

Thursday’s Biggest Winners and Losers in the S&P 500

Why This Alzheimer’s Study Is Crushing Biogen Shares

Major Biotechs See a Rising Tide in Short Interest

Are Nightstar Shareholders Getting Enough in the Buyout?

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Top Analyst Upgrades and Downgrades: Agilent, American Water, Apple, Biogen, Garmin, GoDaddy, Tilray, UBS, Walmart and More

Top Analyst Upgrades and Downgrades: Activision, Biogen, Deere, DocuSign, Ford, Freeport-McMoRan, GM, Lattice Semi, Qualys, Shopify, Under Armour and More

Short Sellers Run for Cover From Major Biotechs

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Sellers Back Off Major Biotechs

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Biogen : BIIB

All Biogen Articles

Picking Up the Pieces: How Biogen Is Dealing With Discontinued Alzheimer’s Trial

Top Analyst Upgrades and Downgrades: Best Buy, Biogen, Booking, China Mobile, Chipotle, CNOOC, Kinder Morgan, Lumentum, MongoDB, Nike and More

Is Neurotrope the Default Alzheimer’s Winner After Biogen’s Implosion?

Thursday’s Biggest Winners and Losers in the S&P 500

Why This Alzheimer’s Study Is Crushing Biogen Shares

Major Biotechs See a Rising Tide in Short Interest

Are Nightstar Shareholders Getting Enough in the Buyout?

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, UTC, Zillow and More

Johnson & Johnson and Other Health Care Stocks With Recent Death Crosses

Top Analyst Upgrades and Downgrades: Agilent, American Water, Apple, Biogen, Garmin, GoDaddy, Tilray, UBS, Walmart and More

Top Analyst Upgrades and Downgrades: Activision, Biogen, Deere, DocuSign, Ford, Freeport-McMoRan, GM, Lattice Semi, Qualys, Shopify, Under Armour and More

Short Sellers Run for Cover From Major Biotechs

Reality Check: Big Biotech and Big Pharma Are Becoming Identical

Short Sellers Back Off Major Biotechs

‘Traders Need to Be Really Careful Here’: Schwab on the Fed Decision and Powell’s Uncertain Future

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

This Dividend ETF Is up 30% in 6 Months With a 3.7% Dividend Yield

Featured Reads

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Long-Term Care Could Cost This 68-Year-Old Couple $380,000 and Their $2.1 Million Portfolio Is Not Structured for It